All terms
    Investment & FinanceStartup Lifecycle

    Drag-Along and Tag-Along Rights

    Stockholder agreement provisions that compel minority holders to join a sale (drag) or entitle them to participate pro rata in a major holder's sale (tag).

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 9, 2026

    Definition

    Drag-along rights allow specified majority stockholders (typically the board plus a preferred-stock supermajority) to compel minority stockholders to sell their shares on the same terms in a qualifying sale of the company, ensuring a buyer can acquire 100% of the equity. Tag-along (co-sale) rights give minority stockholders the right to participate pro rata in a large stockholder's sale to a third party, preventing founders or early investors from cashing out at a price the smaller holders cannot access. Both are standard NVCA-form provisions.
    What the regulation says
    Drag-along and tag-along rights are contractual investment terms, not MedTech-specific regulatory requirements. The National Venture Capital Association (NVCA) provides model provisions through its Voting Agreement for drag-along rights and its Right of First Refusal and Co-Sale Agreement for tag-along rights. These models are drafting frameworks, not binding regulations. The executed agreements determine approval thresholds, covered transactions, participation rights, notice procedures and exceptions. A drag-along provision does not itself replace corporate approvals required by law or automatically eliminate statutory appraisal rights. For Delaware corporations, the Delaware General Corporation Law supplies the statutory framework: Title 8, § 202 addresses restrictions on stock transfers; § 218 addresses stockholder voting agreements; § 251 governs merger agreements and approvals; and § 262 governs appraisal rights. Section 122(18), effective August 1, 2024, expressly authorizes certain contracts between corporations and current or prospective stockholders, subject to statutory limits, including consistency with the certificate of incorporation and Delaware law. It does not make every drag-along or co-sale clause enforceable. Enforceability depends on the agreement, applicable corporate law and transaction facts. These rights concern ownership and exit arrangements, not medical-device market authorization.

    What this means in practice

    MedTech founders should understand drag thresholds carefully; they determine who must agree to a sale. Tag-along rights are especially important to early angels and seed investors.

    Examples

    • A MedTech startup's board decides to sell the company to a larger firm, activating a drag-along clause that compels all seed investors to sell their shares on the same terms.
    • An early angel investor, holding a small stake in a MedTech company, uses their tag-along rights to join a large Series A investor's sale of a significant portion of their shares to a new institutional buyer.
    • To avoid holding out by a few small stockholders, a MedTech company contemplating an acquisition relies on a drag-along provision in its stockholder agreement to ensure a 100% equity transfer to the acquirer.
    Common pitfalls
    • •Setting a drag threshold so high (e.g., requiring common-stockholder supermajority) that a clean exit becomes structurally hard.

    Frequently asked questions

    A drag-along right allows the stockholders specified in the governing agreement, typically the board together with a preferred stock supermajority, to compel all other minority stockholders to sell their shares on the same terms in a qualifying company sale, which is essential for a buyer that wants or needs to acquire 100 percent of the company's equity in the transaction. Without an effective drag-along mechanism, even a small number of holdout minority stockholders could block or complicate an otherwise agreed sale.
    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Ecosystems (1)

    Latest in MedTech

    Sources

    3 sources

    Every citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

    Tier 1Binding law and standards· 1Tier 4Trade press and expert commentary· 2
    Link health: 3 verified· last checked 2026-06-20
    NVCA·1DE Code·1PitchBook·1
    1. 1
      NVCA Model Legal Documents
      Tier 4 Verified
      NVCAnvca.org
    2. 2
      Delaware General Corporation Law (Title 8)
      Tier 1 Verified
      DE Codedelcode.delaware.gov
    3. 3
      PitchBook - MedTech Coverage
      Tier 4 Verified
      PitchBookpitchbook.com

    Inline markers like [1] jump to the matching reference above.